Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Oligometastatic Prostate Cancer × Radiosurgery × Clear all

Phase

Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 40 Prostatic Neoplasms 30 Pancreatic Neoplasms 25 Brain Neoplasms 24 Lung Neoplasms 23 Neoplasm Metastasis 20 Melanoma 19 Carcinoma, Hepatocellular 16 Breast Neoplasms 15 Carcinoma, Renal Cell 11 Colorectal Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 8 Neoplasms 8 Small Cell Lung Carcinoma 7 Recurrence 5 Glioblastoma 5 Urinary Bladder Neoplasms 4 Sarcoma 4 Liver Neoplasms 4 Kidney Neoplasms 4 Adenocarcinoma of Lung 4 Uterine Cervical Neoplasms 3 Clear-cell metastatic renal cell carcinoma 3 Cholangiocarcinoma 3 Uveal Melanoma 2 Unresectable Locally Recurrent Rectal Cancer 2 Rectal Neoplasms 2 Ovarian Neoplasms 2 Osteosarcoma 2 NSCLC 2

Interventions

zimberelimab 1 quemliclustat 1 Radiosurgery 1 Androgen Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05915442 2025-05-20

SBRT-AMICO

Columbia University

Phase 2 Recruiting

Oligometastatic Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡